Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Our founding partners

Start Codon was co-founded by Dr Jason Mellad and Daniel Rooke, alongside leading organisations and individuals in the venture capital and life sciences sector, to identify, fund, de-risk and drive the success of truly disruptive life science and healthcare startups from across the UK and beyond.

Our founding partners

  • CIC Logo

    Cambridge Innovation Capital

    Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. Cambridge Innovation Capital is the preferred investor for the University of Cambridge, and has extensive access to investment opportunities in the ecosystem. and beyond

  • Genentech


    Genentech is a biotechnology company dedicated to pursuing ground-breaking science to discover and develop medicines for people with serious and life-threatening diseases. Their transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

  • Ian tomlinson

    Dr Ian Tomlinson

    Ian is a pharma R & D leader, biotech entrepreneur and antibody engineer. Ian was previously the co-founder (alongside Sir Greg Winter) and CSO for Domantis, which was sold in January 2007 to GSK for $454m. Ian has previously been SVP and Head of Worldwide Business Development for GSK and chair of both Stevenage Bioscience Catalyst and Apollo Therapeutics.

  • Babraham

    Babraham Research Campus

    Babraham Research Campus Ltd is responsible for the development and management of the Campus on behalf of its shareholders; BBSRC-UKRI and the Babraham Institute. The Campus is one of the UK’s leading places to support early-stage bioscience enterprise and is distinct in its co-location of bioscience companies with the Babraham Institute.

  • Meltwind

    Dr Jonathan Milner and Meltwind Advisory

    Dr Jonathan Milner (founder and former CEO of Abcam) is a serial biotech investor and entrepreneur. Jonathan actively invests as an angel across the life sciences and tech spaces, supporting early-stage companies throughout their journey. Jonathan is assisted in his investment activities by Meltwind Advisory, his due diligence and portfolio management organisation which is run by his adviser, Mike Murphy.

Our partners and collaborators

  • Novartis logo pos rgb
  • Genentech
  • CIC Logo
  • Meltwind
  • Puhua Capital
  • Combined Authority Non Mayoral Logo Portrait
  • Babraham
  • Milner
  • Kin Fund Services MASTER 1
  • Cancer research
  • CRH Black
  • Zyme
  • SVB
  • Taylor Wessing
  • Wilson Sonsini Stack Standard RGB
  • Charles river logo
  • Lonza
  • HSBC Logo
  • PEM Core Logo Main
  • BIA
  • Venner Shipley transparent
  • TTP logo
  • Partners
  • Kpmg logo
  • CJBS
  • ARU
  • CN
  • Image005
  • HIE RGB Full Colour positive inline32
  • IT4 S Logo
  • Logo full black noborder